Overexpression of microRNA-107 suppressed proliferation, migration, invasion, and the PI3K/Akt signaling pathway and induced apoptosis by targeting Nin one binding (NOB1) protein in a hypopharyngeal squamous cell carcinoma cell line (FaDu)

References

• Lee MS, Ho HC, Hsiao SH, et al. Treatment results and prognostic factors in locally advanced hypopharyngeal cancer. Acta Otolaryngol. 2008;128:103–109.
   PubMed Web of Science ®Google Scholar
• Xu S, Hui L, Yang N, et al. Upregulation of microRNA‑194‑5p inhibits hypopharyngeal carcinoma cell proliferation, migration and invasion by targeting SMURF1 via the mTOR signaling pathway. Int J Oncol. 2019;54:1245–1255.
   PubMed Web of Science ®Google Scholar
• Kikkawa N, Kinoshita T, Nohata N, et al. microRNA-504 inhibits cancer cell proliferation via targeting CDK6 in hypopharyngeal squamous cell carcinoma. Int J Oncol. 2014;44:2085–2092.
   PubMed Web of Science ®Google Scholar
• Eckel HE, Bradley PJ. Treatment options for hypopharyngeal cancer. Adv Otorhinolaryngol. 2019;83:47–53.
   PubMedGoogle Scholar
• Fukumoto I, Kinoshita T, Hanazawa T, et al. Identification of tumour suppressive microRNA-451a in hypopharyngeal squamous cell carcinoma based on microRNA expression signature. Br J Cancer. 2014;111:386–394.
   PubMed Web of Science ®Google Scholar
• Jing P, Sa N, Liu X, et al. MicroR-140-5p suppresses tumor cell migration and invasion by targeting ADAM10-mediated Notch1 signaling pathway in hypopharyngeal squamous cell carcinoma. Exp Mol Pathol. 2016;100:132–138.
   PubMed Web of Science ®Google Scholar
• Wong TS, Liu XB, Wong BY, et al. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res off J Am Assoc Cancer Res. 2008;14:2588–2592.
   PubMed Web of Science ®Google Scholar
• Datta J, Smith A, Lang JC, et al. microRNA-107 functions as a candidate tumor-suppressor gene in head and neck squamous cell carcinoma by downregulation of protein kinase Cɛ. Oncogene. 2012;31:4045–4053.
   PubMed Web of Science ®Google Scholar
• Sharma P, Saraya A, Gupta P, et al. Decreased levels of circulating and tissue miR-107 in human esophageal cancer. Biomarkers. 2013;18:322–330.
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Z, Zhang K, et al. MicroRNA-107 inhibits proliferation and invasion of laryngeal squamous cell carcinoma cells by targeting CACNA2D1 in vitro. Anticancer Drugs. 2020;31:260–271.
   PubMed Web of Science ®Google Scholar
• Hui AB, Lin A, Xu W, et al. Potentially prognostic miRNAs in HPV-associated oropharyngeal carcinoma. Clin Cancer Res off J Am Assoc Cancer Res. 2013;19:2154–2162.
   PubMed Web of Science ®Google Scholar
• Wang J, Xi X, Shang W, et al. The molecular differences between human papillomavirus-positive and -negative oropharyngeal squamous cell carcinoma: a bioinformatics study. Am J Otolaryngol. 2019;40:547–554.
   PubMed Web of Science ®Google Scholar
• Xu J, Hao Y, Gao X, et al. CircSLC7A6 promotes the progression of Wilms’ tumor via microRNA-107/ ABL proto-oncogene 2 axis. Bioengineered. 2022;13:308–318.
   PubMed Web of Science ®Google Scholar
• Xia H, Li Y, Lv X. MicroRNA-107 inhibits tumor growth and metastasis by targeting the BDNF-mediated PI3K/AKT pathway in human non-small lung cancer. Int J Oncol. 2016;49:1325–1333.
   PubMed Web of Science ®Google Scholar
• Chen J, Wang J, Cui X, et al. Positive nin one binding protein expression predicts poor outcome in prostate cancer. Mol Med Rep. 2015;11:2671–2676.
   PubMed Web of Science ®Google Scholar
• Lin S, Meng W, Zhang W, et al. Expression of the NOB1 gene and its clinical significance in papillary thyroid carcinoma. J Int Med Res. 2013;41:568–572.
   PubMed Web of Science ®Google Scholar
• He X-W, Feng T, Yin Q-L, et al. NOB1 is essential for the survival of RKO colorectal cancer cells. World J Gastroenterol. 2015;21(3):868–877.
   PubMed Web of Science ®Google Scholar
• Yin J, Wang J, Jiang Y, et al. Downregulation of NOB1 inhibits proliferation and promotes apoptosis in human oral squamous cell carcinoma. Oncol Rep. 2015;34(6):3077–3087.
   PubMed Web of Science ®Google Scholar
• Lin Y, Peng S, Yu H, et al. RNAi-mediated downregulation of NOB1 suppresses the growth and colony-formation ability of human ovarian cancer cells. Med Oncol. 2012;29(1):311–317.
   PubMed Web of Science ®Google Scholar
• Gao X, Wang J, Bai W, et al. NOB1 silencing inhibits the growth and metastasis of laryngeal cancer cells through the regulation of JNK signaling pathway. Oncol Rep. 2016;35(6):3313–3320.
   PubMed Web of Science ®Google Scholar
• Wang T, Zhang Y, Cui B, et al. miR-4530 inhibits the malignant biological behaviors of human glioma cells by directly targeting RTEL1. Acta Biochim Biophys Sin (Shanghai). 2020;52(12):1394–1403.
   PubMed Web of Science ®Google Scholar
• Ma L, He H, Jiang K, et al. FAM46C inhibits cell proliferation and cell cycle progression and promotes apoptosis through PTEN/AKT signaling pathway and is associated with chemosensitivity in prostate cancer. Aging (Albany NY). 2020;12(7):6352–6369.
   PubMedGoogle Scholar
• Ning L, Zhang M, Zhu Q, et al. miR-25-3p inhibition impairs tumorigenesis and invasion in gastric cancer cells in vitro and in vivo. Bioengineered. 2020;11(1):81–90.
   PubMed Web of Science ®Google Scholar
• Shang C, Hong Y, Guo Y, et al. Mir-338-3p inhibits malignant biological behaviors of glioma cells by targeting MACC1 gene. Med Sci Monit. 2016;22:710–716.
   PubMed Web of Science ®Google Scholar
• Dong Y, Zheng Y, Wang C, et al. MiR-876-5p modulates head and neck squamous cell carcinoma metastasis and invasion by targeting vimentin. Cancer Cell Int. 2018;18(1):121.
   PubMedGoogle Scholar
• Peng X, Liu Y, Zhu S, et al. Co-targeting PI3K/Akt and MAPK/ERK pathways leads to an enhanced antitumor effect on human hypopharyngeal squamous cell carcinoma. J Cancer Res Clin Oncol. 2019;145(12):2921–2936.
   PubMed Web of Science ®Google Scholar
• Hong Y, Chen X, Liang Z, et al. MiR-338-3p inhibits cell migration and invasion in human hypopharyngeal cancer via downregulation of ADAM17. Anticancer Drugs. 2020;31(9):925–931.
   PubMed Web of Science ®Google Scholar
• Chen J, Zhou X, Xiao Q, et al. MiR-107 suppresses cell proliferation and tube formation of Ewing sarcoma cells partly by targeting HIF-1β. Hum Cell. 2018;31(1):42–49.
   PubMed Web of Science ®Google Scholar
• Zhao G, Wei Z, Guo Y. MicroRNA-107 is a novel tumor suppressor targeting POU3F2 in melanoma. Biol Res. 2020;53(1):11.
   PubMed Web of Science ®Google Scholar
• Liu F, Liu S, Ai F, et al. miR-107 promotes proliferation and inhibits apoptosis of colon cancer cells by targeting prostate apoptosis response-4 (Par4). Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 2017;25(6):967–974.
   Google Scholar
• Takahashi Y, Forrest ARR, Maeno E, et al. MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines. PloS one. 2009;4(8):e6677.
   PubMed Web of Science ®Google Scholar
• Ai H, Zhou W, Wang Z, et al. microRNAs-107 inhibited autophagy, proliferation, and migration of breast cancer cells by targeting HMGB1. J Cell Biochem. 2018. DOI:10.1002/jcb.28157
   Web of Science ®Google Scholar
• Lee M, Lee YK, Jeon TJ, et al. Frequent visualization of thyroglossal duct remnant on post-ablation 131I-SPECT/CT and its clinical implications. Clin Radiol. 2015;70(6):638–643.
   PubMed Web of Science ®Google Scholar
• Huang Y, Zhu H, Ji X, et al. TBX3 knockdown suppresses the proliferation of hypopharyngeal carcinoma FaDu cells by inducing G1/S cell cycle arrest and apoptosis. Oncol Lett. 2020;19(1):113–120.
   PubMed Web of Science ®Google Scholar
• Cheng F, Yang Z, Huang F, et al. microRNA-107 inhibits gastric cancer cell proliferation and metastasis by targeting PI3K/AKT pathway. Microb Pathog. 2018;121:110–114.
   PubMed Web of Science ®Google Scholar
• Xiong J, Wang D, Wei A, et al. Deregulated expression of miR-107 inhibits metastasis of PDAC through inhibition PI3K/Akt signaling via caveolin-1 and PTEN. Exp Cell Res. 2017;361(2):316–323.
   PubMed Web of Science ®Google Scholar
• Wang C, Lin C, Tao Q, et al. Evaluation of calcium-binding protein A11 promotes the carcinogenesis of hypopharygeal squamous cell carcinoma via the PI3K/AKT signaling pathway. Am J Transl Res. 2019;11(6):3472–3480.
   PubMed Web of Science ®Google Scholar
• Zhang J, An X, Han Y, et al. Overexpression of JARID1B promotes differentiation via SHIP1/AKT signaling in human hypopharyngeal squamous cell carcinoma. Cell Death Dis. 2016;7(9):e2358.
   PubMedGoogle Scholar
• Sharma VR, Gupta GK, Sharma AK, et al. PI3K/Akt/mTOR intracellular pathway and breast cancer: factors, mechanism and regulation. Curr Pharm Des. 2017;23(11):1633–1638.
   PubMed Web of Science ®Google Scholar
• Ediriweera MK, Tennekoon KH, Samarakoon SR. Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer: biological and therapeutic significance. Semin Cancer Biol. 2019;59:147–160.
   PubMed Web of Science ®Google Scholar
• Yongchun Z, Linwei T, Xicai W, et al. MicroRNA-195 inhibits non-small cell lung cancer cell proliferation, migration and invasion by targeting MYB. Cancer Lett. 2014;347(1):65–74.
   PubMed Web of Science ®Google Scholar
• Cheng H, Wang W, Wang G, et al. Silencing ras-related C3 botulinum toxin substrate 1 inhibits growth and migration of hypopharyngeal squamous cell carcinoma via the P38 mitogen-activated protein kinase signaling pathway. Med Sci Monit. 2018;24:768–781.
   PubMed Web of Science ®Google Scholar